The UK and South America: A Tale of Two Different Insulin...

Ajouter une nouvelle offre d'emploi Health

2026-02-05 11:19:34 -

The UK and South America: A Tale of Two Different Insulin Biosimilars Markets

The UK has always had a "common sense" approach to health, and the UK Insulin Biosimilars Market reflects that. In 2026, the NHS has fully embraced biosimilars to save billions of pounds. What’s cool is that they’re reinvesting those savings into newer tech, like continuous glucose monitors. It’s a win-win: the system saves money, and the patients get access to even...

0 Commentaires 0 Parts 39 Vue 0 Aperçu